BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37832654)

  • 1. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
    Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
    Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
    Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
    Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insight into the study of adult T-cell leukemia/lymphoma (ATLL): Ten-year studies on HTLV-1 associated diseases in an endemic region.
    Ashrafi F; Rahimzada M; Parandi M; Mirhosseini A; Mashkani B; Ahmadi Ghezeldasht S; Soltani A; Rafatpanah H; Mosavat A; Abdolrahim Rezaee S
    Gene; 2022 Dec; 847():146885. PubMed ID: 36108787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling factors potentially associated to the pathogenesis of Adult T-cell leukemia /lymphoma: A network-analysis and novel findings assessment.
    Mozhgani SH; Zarei Ghobadi M; Norouzi M; Rahimi H; Valizadeh N; Teymoori-Rad M; Tarokhian H; Ostadali M; Farajifard H; Rezaee SA
    Virus Res; 2022 Oct; 319():198875. PubMed ID: 35868352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
    Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
    Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
    Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
    BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of joint gene players implicated in the pathogenesis of HTLV-1 and BLV through a comprehensive system biology analysis.
    Ashrafi F; Ghezeldasht SA; Ghobadi MZ
    Microb Pathog; 2021 Nov; 160():105153. PubMed ID: 34419613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK/JNK signal transduction pathway in Adult T-cell leukemia/lymphoma.
    Shadabi S; Delrish N; Norouzi M; Ehteshami M; Habibian-Sezavar F; Pourrezaei S; Madihi M; Ostadali M; Akhgar F; Shayeghpour A; Razavi Pashabayg C; Aghajanian S; Mozhgani SH; Jazayeri SM
    Infect Agent Cancer; 2021 Jun; 16(1):49. PubMed ID: 34187521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
    Zarei Ghobadi M; Emamzadeh R
    PLoS One; 2022; 17(1):e0262739. PubMed ID: 35041720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
    Ohshima K
    Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
    Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
    Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.
    Macaire H; Riquet A; Moncollin V; Biémont-Trescol MC; Duc Dodon M; Hermine O; Debaud AL; Mahieux R; Mesnard JM; Pierre M; Gazzolo L; Bonnefoy N; Valentin H
    J Biol Chem; 2012 Jun; 287(25):21357-70. PubMed ID: 22553204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia/lymphoma.
    Jo T; Noguchi K; Sakai T; Kubota-Koketsu R; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
    Cancer Med; 2022 Sep; 11(17):3238-3250. PubMed ID: 35315593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
    Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
    BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.
    Ramezani S; Shirdel A; Rafatpanah H; Akbarin MM; Tarokhian H; Rahimi H; Bari A; Jahantigh HR; Rezaee SA
    Med Microbiol Immunol; 2017 Aug; 206(4):327-335. PubMed ID: 28466382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic, immunophenotypic and ultrastructrual analyses of ATLL patients with cutaneous involvement.
    Wang C; Yao Z; Liao J; Luo Y; Ma Y; Chen G; Zhu W
    Chin Med J (Engl); 1999 May; 112(5):461-5. PubMed ID: 11593520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
    Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
    J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis.
    Shimizu K; Karube K; Arakawa F; Nomura Y; Komatani H; Yamamoto K; Yoshida S; Aoki R; Sugita Y; Takeshita M; Ohshima K
    Cancer Sci; 2007 Dec; 98(12):1875-80. PubMed ID: 17900259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.
    Yoshida N; Yamada K; Ohshima K
    Cancer Sci; 2021 Apr; 112(4):1339-1347. PubMed ID: 33576080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals.
    Letafati A; Mozhgani SH; Marjani A; Amiri A; Siami Z; Mohammaditabar M; Molaverdi G; Hedayatyaghoobi M
    Med Oncol; 2023 Oct; 40(11):317. PubMed ID: 37792095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.